ReLive Acquires Co.Don

Co.Don is a biopharmaceutical company and manufacturer of cell transplants that focuses on the development, manufacture, and marketing of regenerative, joint-preserving cell therapies for the treatment of cartilage defects in joints with the body's own cells. It enables patients to lead active life through personalized cartilage cell therapy. In line with the corporate vision, it is actively working to make its EU-wide approved drug available in other European countries and thus more patients. Co.Don is headquartered in Germany (Leipzig, Teltow) and is also active in England, the Netherlands, Austria, and Switzerland.